Abstract
WuXi STA, the small-molecule drug arm of WuXi AppTec, one of the world’s largest pharmaceutical service firms, plans to build a plant in Middletown, Delaware. WuXi STA announced the project June 28, after the state of Delaware approved a $19 million grant supporting it. Expected to open in 2024 and employ about 500 people by 2026, the project is a major step in WuXi STA’s international expansion effort. The business is based in China and operates several facilities there. It opened a small facility in San Diego in 2016 and agreed earlier this year to buy a Bristol Myers Squibb plant in Switzerland . In addition to unspecified capacity for making active pharmaceutical ingredients, the Delaware plant will feature testing labs and facilities for packaging of solid-dose and sterile drugs. WuXi STA says its long-term plans call for creating 1,000 jobs at the site, which is being developed on about
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
